DNA damaging agents and immunotherapy in NSCLC: Is there a STING in the tale?
Della Corte, C.M., Ramkumar, K., Sen, T., Tong, P., Gibbons, D.L., Heymach, J.V., Wang, J., Fan, Y.-H., Cardnell, R., Byers, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A high-throughput drug screen identifies new therapeutic vulnerabilities in non-small cell lung cancers (NSCLC) with overexpression of the EMT-associated receptor tyrosine kinase AXL
Cardnell, R, Tong, P, Giri, U, Gudikote, J, Banerjee, U, Kalu, N, Fan, Y, Nilsson, M, Johnson, F, Tran, H, Wang, J, Heymach, J, Byers, L
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Polymorphisms in Genes Involved in Nitric Oxide (NO) Signaling and the Risk for Late Normal Tissue Injury From Radiation Therapy (RT)
Mikkelsen, R.B, Alam, A, Cardnell, R, Howlett, E, Reshko, L, Walker, L, Ning, Y, Anscher, M
Published in International journal of radiation oncology, biology, physics (01.11.2012)
Published in International journal of radiation oncology, biology, physics (01.11.2012)
Get full text
Journal Article
Genomic landscape of small cell neuroendocrine cervical cancer
Hillman, R.T., Cardnell, R., Fujimoto, J., Byers, L.A., Futreal, P.A., Frumovitz, M.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article
163P Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: Findings from the CAVE-lung trial
Della Corte, C.M., Fasano, M., Ciaramella, V., Cimmino, F., Cardnell, R., Gay, C.M., Ramkumar, K., Diao, L., Di Liello, R., Viscardi, G., Famiglietti, V., Ciardiello, D., Martini, G., Napolitano, S., Troiani, T., Martinelli, E., Wang, J., Byers, L., Morgillo, F., Ciardiello, F.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
SCLC subtype-enriched biomarkers define positioning of Aurora B inhibitor combination with venetoclax
Della Corte, C., Gay, C., Urosevic, J., Polanska, U., Ajpacaja, L., Wijnhoven, P., Wang, J., Coker, E., Fabbri, G., Jaaks, P., Jerome, M., Cosaert, J., Garnett, M., Cardnell, R., Pease, J.E., Travers, J., Byers, L.A.
Published in European journal of cancer (1990) (01.10.2020)
Published in European journal of cancer (1990) (01.10.2020)
Get full text
Journal Article
1736P Elevated AXL expression following SARS-CoV-2 infection in non-small cell lung cancer
Ramkumar, K., Stewart, C.A., Gay, C., Cardnell, R., Diao, L., Wang, Q., Shen, L., Xi, Y., Kundu, S., Della Corte, C., Gibbons, D., Wang, J., Heymach, J.V., Byers, L.A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1745P SARS-CoV-2 infects metabolically-primed epithelial cells in lung cancer models
Cargill, K.R., Stewart, C.A., Gay, C., Ramkumar, K., Cardnell, R., Nilsson, M., Heeke, S., Park, E.M., Diao, L., Wang, Q., Shen, L., Le, X., Xi, Y., Kundu, K., Gibbons, D., Wang, J., Heymach, J.V., Byers, L.A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1735P SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models
Stewart, C.A., Gay, C., Ramkumar, K., Cargill, K.R., Cardnell, R., Nilsson, M., Heeke, S., Park, E.M., Kundu, S., Diao, L., Wang, Q., Shen, L., Xi, Y., Della Corte, C.M., Kundu, K., Gibbons, D.L., Wang, J., Heymach, J.V., Byers, L.A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
142PDNA damaging agents and immunotherapy in NSCLC: Is there a STING in the tale?
Della Corte, C M, Ramkumar, K, Sen, T, Tong, P, Gibbons, D L, Heymach, J V, Wang, J, Fan, Y-H, Cardnell, R, Byers, L
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
OA03.06 ASCL1, NEUROD1, and POU2F3 Drive Distinct Subtypes of Small Cell Lung Cancer with Unique Therapeutic Vulnerabilities
Gay, C., Diao, L., Stewart, C., Xi, Y., Cardnell, R., Swisher, S., Roth, J., Glisson, B., Wang, J., Heymach, J., Byers, L.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
1749PActivity of the novel Aurora kinase B inhibitor AZD2811 in biomarker-defined models of small cell lung cancer
Della Corte, C M, Ajpacaja, L, Cardnell, R J, Gay, C M, Wang, Q, Shen, L, Ramkumar, K, Stewart, A C, Fan, Y-H, Adelman, C A, Travers, J, Wang, J, Heymach, J, Byers, L A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
245 - A high-throughput drug screen identifies new therapeutic vulnerabilities in non-small cell lung cancers (NSCLC) with overexpression of the EMT-associated receptor tyrosine kinase AXL
Cardnell, R., Tong, P., Giri, U., Gudikote, J., Banerjee, U., Kalu, N., Fan, Y., Nilsson, M., Johnson, F., Tran, H., Wang, J., Heymach, J., Byers, L.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article